The impact of hyperglycemia on risk of infection and early death during induction therapy for acute lymphoblastic leukemia (ALL)

Pediatric Blood and Cancer

Volumn 60, Issue 12, 2013, Pages

  Dare, Julianne M ^a   Moppett, John P ^a   Shield, Julian Ph ^b   Hunt, Linda P ^b   Stevens, Michael Cg ^a,b  

^a BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Children; Hyperglycemia; Infection; Leukemia

Indexed keywords

DEXAMETHASONE; GLUCOSE; INSULIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; ASPERGILLUS; BACTERIAL INFECTION; BODY MASS; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD CANCER; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN SYNDROME; FEMALE; FUNGAL MENINGITIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; INDUCTION CHEMOTHERAPY; INFECTION RISK; INSULIN TREATMENT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MYCOSIS; PANCREATITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS; RETROSPECTIVE STUDY; SCHOOL CHILD; SEPTICEMIA;

CHILDREN; HYPERGLYCEMIA; INFECTION; LEUKEMIA;

BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERGLYCEMIA; INCIDENCE; INDUCTION CHEMOTHERAPY; MALE; MYCOSES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS;

EID: 84885795873     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24689     Document Type: Article

References (18)

1. Koltin D, Sung L, Naqvi A, et al. Medication induced diabetes during induction in pediatric acute lymphoblastic leukemia: Prevalence, risk factors, and characteristics. Support Care Cancer 2012; 20:2009-2015.
2. Pui CH, Burghen GA, Bowman WP, et al. Risk-factors for hyperglycemia in childhood leukemia patients receiving asparaginase and prednisone. J Pediatrics 1981; 99:46-50.
3. Belgaumi A, Al-Bakrah M, Al-Mahr M, et al. Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin. Cancer 2003; 97:2898-2903.
4. Lowas SR, Marks D, Malempati S. Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia. Pediatric Blood Cancer 2009; 52:814-818.
5. Sonabend RY, Mckay SV, Okcu MF, et al. Hyperglycemia during induction therapy is associated with increased infectious complications in childhood acute lymphocytic leukemia. Pediatric Blood Cancer 2008; 51:387-392.
6. Roberson JR, Spraker HL, Shelso J, et al. Clinical consequences of hyperglycemia during remission induction therapy for pediatric acute lymphoblastic leukemia. Leukemia 2009; 23:245-250.
7. Cetin M, Yetgin S, Kara A, et al. Hyperglycemia, ketoacidosis, and other complications of l-asparaginase in children with acute lymphoblastic leukemia. J Med 1994; 25:219-229.
8. Ali NA, O'Brien JM, Blum W, et al. Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality. Cancer 2007; 110:96-102.
9. Weiser MA, Cabanillas ME, Konopleva M, et al. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate/cytarabine regimen. Cancer 2004; 100:1179-1185.
10. Gabir MM, Hanson RL, Dabelea D, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 2000; 23:1108-1112.
11. Cole TJ, Freeman JV, Preece MA. Body mass index reference curves for the UK 1990 Arch Dis Child 1995 73:25-29.
12. Hirshberg E, Larsen G, Van Duker H. Alterations in glucose homeostasis in the pediatric intensive care unit: Hyperglycemia and glucose variability are associated with increased mortality and morbidity. Pediatr Crit Care Med 2008; 9:361-366.
13. Derr R, Hsiao V, Saudek C. Antecedent hyperglycemia is associated with an increased risk of neutropenic infections during Bone Marrow Transplantation. Diabetes Care 2008; 31:1972-1977.
14. Howard S, Pui C. Endocrine complications in pediatric patients with acute lymphoblastic leukemia. Blood Rev 2002; 16:225-243.
15. Turina M, Fry DE. Polk HC, Jr. Acute hyperglycemia and the innate immune system: Clinical, cellular, and molecular aspects. Crit Care Med 2005; 33:1624-1633.
16. Anwar AJ, Walker JD, Frier BM. Type 1 diabetes mellitus and Down's syndrome: Prevalence, management and diabetic complications. Diabet Med 1998; 15:160-163.
17. Bergholdt R, Eising S, Nerup J, et al. Increased prevalence of Down's syndrome in individuals with type 1 diabetes in Denmark: A nationwide population-based study. Diabetologia 2006; 49:1179-1182.
18. Gillespie KM, Dix RJ, Williams AJ, et al. Islet autoimmunity in children with Down's syndrome. Diabetes 2006; 55:3185-3188.